Actionnariat et activité des initiés pour Larimar Therapeutics, Inc. (LRMR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.93 |
| Capitalisation | $408M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-06 | Hamilton Thomas Edward | P-Purchase | 50,000 | $167K |
| 2026-05-19 | Flynn James E | A-Award | 55,150 | $184K |
| 2026-05-19 | LEFF JONATHAN S | A-Award | 55,150 | $184K |
| 2026-05-19 | SHERMAN JEFFREY W | A-Award | 55,150 | $184K |
| 2026-05-19 | Truitt Joseph | A-Award | 55,150 | $184K |
| 2026-05-19 | THOMAS FRANK E | A-Award | 55,150 | $184K |
| 2026-05-19 | Hamilton Thomas Edward | A-Award | 55,150 | $184K |
| 2026-02-27 | Flynn James E | P-Purchase | 1,084,012 | $5.4M |
| 2026-02-27 | Flynn James E | P-Purchase | 1,084,010 | $5.4M |
| 2026-02-27 | Flynn James E | P-Purchase | 831,978 | $4.2M |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $32.4M | $40.8M | $49.3M | $1.0M | $68.1M | $70.1M | $26.8M | $26.7M | $33.2M | $85.4M |
| Placements à Court Terme | $96.8M | $61.3M | $68.7M | 0 | $24.5M | 0 | $91.6M | $60.0M | $150.2M | $51.4M |
| Créances | $347000 | $946000 | $1.5M | $158000 | $32000 | $208000 | 0 | $332000 | $1.1M | $747000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $130.9M | $104.9M | $121.3M | $4.8M | $98.0M | $72.2M | $120.7M | $90.2M | $195.3M | $142.0M |
| Immobilisations Corporelles | $661000 | $528000 | $375000 | $361000 | $5.0M | $4.5M | $3.7M | $3.8M | $3.7M | $2.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $131.6M | $105.5M | $121.8M | $5.2M | $104.7M | $78.7M | $126.4M | $95.9M | $200.2M | $145.8M |
| Dettes Fournisseurs | 0 | 0 | $909000 | $3.5M | $2.6M | $1.7M | $1.7M | $1.3M | $2.4M | $5.2M |
| Dette à Court Terme | $3.6M | 0 | $5.5M | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M |
| Passifs Courants | $9.9M | $7.3M | $13.3M | $5.9M | $9.0M | $8.8M | $10.7M | $9.5M | $24.4M | $64.8M |
| Dette à Long Terme | 0 | $20.0M | $15.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $9.9M | $27.3M | $28.5M | $5.9M | $15.0M | $14.3M | $15.5M | $14.2M | $28.4M | $67.8M |
| Réserves | -$237.5M | -$289.6M | -$350.9M | -$23.1M | -$65.6M | -$116.2M | -$151.6M | -$188.6M | -$269.2M | -$434.8M |
| Capitaux Propres | $121.7M | $78.2M | $93.3M | -$694000 | $89.7M | $64.4M | $110.9M | $81.7M | $171.8M | $78.1M |
| Dette Totale | $3.6M | $20.0M | $20.6M | $97000 | $6.5M | $6.0M | $5.4M | $5.5M | $5.1M | $4.1M |
| Dette Nette | -$125.6M | -$82.1M | -$97.4M | -$912000 | -$86.1M | -$64.1M | -$113.0M | -$81.2M | -$178.3M | -$132.8M |
| Fonds de Roulement | $121.0M | $97.6M | $108.0M | -$1.1M | $89.0M | $63.4M | $110.0M | $80.7M | $170.9M | $77.2M |
Santé financière
| Dette / Capitaux propres | 0.04 |
| Ratio de liquidité | 4.70 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.98 |
Rentabilité
| Rentabilité des capitaux propres | -137.39% |
| Rentabilité du capital investi | -135.25% |
| Rentabilité des actifs | -104.42% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACIU · ALT · AMRN · ANNX · ANRO · DBVT · ENGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de LRMR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions